Clinical Trials Performance

The NIHR Imperial BRC is committed to ensuring faster and easier clinical research, increasing the number of patients who have the opportunity to participate in research, and enhancing the attractiveness of the UK as a location for commercially-sponsored research. The performance of the BRC is measured against established Department of Health benchmarks and monitored quarterly.

We aim for all interventional clinical trials to be initiated within 70 calendar days, and for all commercially-sponsored clinical trials to deliver to agreed times and targets. Our operating procedures ensure all clinical research studies are assessed for:

  • quality, feasibility, and strategic fit
  • technical capability and resource capacity
  • financial viability

From July 2013 we have published our performance against these benchmark and these reports can be downloaded below;